Another question to address in future studies is whether the increase in circulating FASN+ EVs is specific for gliomas or pertains also to epithelial cancers, in which FASN is frequently overexpressed and portends a poor prognosis [12,13]. The gene discussed is FASN; the disease is central nervous system cancer.